McKinsey & Co., a leading global consulting firm, has agreed to pay $78 million to settle claims from health insurers and benefit plans that it helped fuel the opioid addiction crisis in the United States. The plaintiffs accused McKinsey of helping drug manufacturers design deceptive marketing plans and boost sales of painkillers. The settlement is the last in a series of settlements McKinsey has reached and is hoped to bring some closure to the families and communities affected by the crisis.
Posts tagged as “OxyContin”
The Drug Enforcement Administration (DEA) announced on Friday that it will be reinstating federal requirements for powerful drugs such as OxyContin and Adderall, which were waived when the COVID-19 pandemic began. This move is seen as a way to address the opioid crisis and ensure that patients are getting the right medications and that they are being used safely and effectively. The new requirements will go into effect in the coming months and the DEA will be working with healthcare providers to ensure compliance.